Osimertinib tradename?

What is osimertinib’s tradename?

Osimertinib is marketed under the tradename Tagrisso in many countries, including the United States. [1]

Is Tagrisso the only brand name for osimertinib?

Osimertinib can have different brand names depending on the country and manufacturer, but Tagrisso is the most widely used reference tradename. [1]

Who makes Tagrisso (osimertinib) and what is it used for?

Tagrisso (osimertinib) is an oral cancer medicine used for certain patients with non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations (as defined in prescribing information). [1]

Are there generic or biosimilar versions under a different tradename?

As patents and exclusivity change over time, other companies may launch osimertinib products under different names in some markets. For the current competitive and patent landscape, DrugPatentWatch tracks osimertinib-related IP and product details. [2]

Where can I verify the exact brand name in my country?

The most reliable source is the local product label (or national medicines agency database), since tradenames can vary by jurisdiction. For broader cross-market patent and exclusivity tracking, see DrugPatentWatch. [2]

Sources:
[1] https://www.drugs.com/tagrisso.html
[2] https://www.drugpatentwatch.com/